Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gore

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|August 24, 2010
Is advanced renal cell carcinoma becoming a chronic disease?James Larkin, Martin Gore
Pharmacogenomics|July 30, 2016
Targeting the mitogen-activated protein kinase pathway in low-grade serous carcinoma of the ovaryJennifer McLachlan, Martin Gore, Susana Banerjee
Seminars in Oncology|August 10, 2002
European approach to adjuvant treatment of intermediate- and high-risk malignant melanomaAlexander M M Eggermont, Martin Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancerMarina Parton, Martin Gore, Tim Eisen
Seminars in Cancer Biology|June 19, 2012
Current and future systemic treatments for renal cell carcinomaRosalie Fisher, Martin Gore, James Larkin
Progress in Tumor Research|September 18, 2015
Immunotherapies in Early and Advanced Renal Cell CancerBenjamin Kasenda, James Larkin, Martin Gore
Seminars in Oncology|December 18, 2007
Randomized adjuvant therapy trials in melanoma: surgical and systemicAlexander M M Eggermont, Martin Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Intraperitoneal chemotherapy in ovarian cancer remains experimentalMartin Gore, Andreas du Bois, Ignace Vergote
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 18, 2003
[Paclitaxel should be included in standard therapy of ovarian carcinoma]Claes Tropé, Janne Kaern, Gunnar Saeter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Adjuvant interferon therapy for melanomaBarry Hancock, Keith Wheatley, Natalie Ives, et al.
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|August 24, 2010
Is advanced renal cell carcinoma becoming a chronic disease?James Larkin, Martin Gore
Pharmacogenomics|July 30, 2016
Targeting the mitogen-activated protein kinase pathway in low-grade serous carcinoma of the ovaryJennifer McLachlan, Martin Gore, Susana Banerjee
Seminars in Oncology|August 10, 2002
European approach to adjuvant treatment of intermediate- and high-risk malignant melanomaAlexander M M Eggermont, Martin Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancerMarina Parton, Martin Gore, Tim Eisen
Seminars in Cancer Biology|June 19, 2012
Current and future systemic treatments for renal cell carcinomaRosalie Fisher, Martin Gore, James Larkin
Progress in Tumor Research|September 18, 2015
Immunotherapies in Early and Advanced Renal Cell CancerBenjamin Kasenda, James Larkin, Martin Gore
Seminars in Oncology|December 18, 2007
Randomized adjuvant therapy trials in melanoma: surgical and systemicAlexander M M Eggermont, Martin Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Intraperitoneal chemotherapy in ovarian cancer remains experimentalMartin Gore, Andreas du Bois, Ignace Vergote
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 18, 2003
[Paclitaxel should be included in standard therapy of ovarian carcinoma]Claes Tropé, Janne Kaern, Gunnar Saeter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Adjuvant interferon therapy for melanomaBarry Hancock, Keith Wheatley, Natalie Ives, et al.
Pageof 14